Azitra, Inc.
ATR-12
Netherton Syndrome
Resolved
7days ago
Phase 2 readout · ~ Jun 30, 2026 estimated
What's at stake
Phase 2 trial results for ATR-12 in Netherton Syndrome are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“Topline data from the Phase 1b trial is anticipated H2 2026.”